NEW PUBLICATION

TwinStrand DuplexSeq measuring MRD in AML

TwinStrand’s DuplexSeq™ Mutagenesis Assay is now owned and operated by Scantox. Follow this link for more information.

Read more about the acquisition in the news.

Publications

Featured Publications

Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing

Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues

All Publications

Filter by

Area of Interest

Date

Archives of Toxicology, Apr. 2024.

Seo, Ji-Eun, et al.

Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing

DOI: 10.1007/s00204-024-03731-4

Cancer Discovery, Mar. 2024, pp. OF1–12.

Sánchez-Guixé, Mònica, et al.

Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues

DOI: 10.1158/2159-8290.CD-23-1186

Nature Ecology & Evolution, Feb. 2024, pp. 1–14.

Serrano, Isabel M., et al.

Mitochondrial haplotype and mito-nuclear matching drive somatic mutation and selection throughout ageing

DOI: 10.1038/s41559-024-02338-3

Preprint, Sexual and Reproductive Health, 13 Feb. 2024.

Axelsson, Jonatan, et al.

Frequency and Spectrum of Mutations in Human Sperm Measured Using Duplex Sequencing Correlate with Trio-Based de Novo Mutation Analyses

DOI: 10.1101/2024.02.13.24302689

Haematologica, vol. 109, no. 2, 2024, pp. 401–10.

Dillon, Laura W., et al.

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia

DOI: 10.3324/haematol.2023.283520

PubMed: 37034683

Nature Genetics, vol. 56, no. 1, Jan. 2024, pp. 23–26.

Koh, Gene Ching Chiek, et al.

The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells

DOI: 10.1038/s41588-023-01602-9

PubMed: 38036782

For Research Use Only. Not for use in diagnostic procedures.

©2026 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners. Legal Notices